EPOCHA-AH 1998–2017. Dynamics of prevalence, awareness of arterial hypertension, treatment coverage, and effective control of blood pressure in the European part of the Russian Federation

Author:

Badin Yu. V.1,Fomin I. V.1,Belenkov Yu. N.2,Mareev V. Yu.3,Ageev F. T.4,Polyakov D. S.1,Artemjeva E. G.5,Galyavich A. S.6,Ionova T. S.7,Kamalov G. M.6,Kechedzhieva S. G.8,Koziolova N. A.9,Malenkova V. Yu.5,Malchikova S. V.10,Smirnova E. A.11,Tarlovskaya E. I.1,Shechrbinina E. V.1,Valikulova F. Yu.1,Vaysberg A. R.1,Yakushin S. S.11

Affiliation:

1. Privolzhsky Research Medical University

2. I. M. Sechenov First Moscow State Medical University (Sechenov University)

3. Lomonosov Moscow State University Medical Research and Educational Center

4. FSBO National Medical research center of cardiology of the Ministry of healthcare of the Russian Federation

5. State Autonomic Institution of Advanced Professional Education “Institution for Continued Medical Education” of the Chuvash Republic Ministry of Healthcare

6. Kazan State Medical University

7. Regional Clinical Cardiological Dispensary

8. Stavropol State Medical University

9. Academician E. A. Vagner Perm State Medical University

10. Kirov State Medical University

11. Ryazan State Medical University

Abstract

Aim.To perform a repeated epidemiological study of a representative sample in the European part of the Russian Federation in 2017 and to compare the dynamics of arterial hypertension (AH) prevalence with the effectiveness of blood pressure (BP) control in the population compared to 1998, 2002, and 2007.Materials and methods.A representative sample of the European part of the Russian Federation was created in 2002 and re-examined in 2007 and 2017. In 1998, a pilot project was performed for examining a representative sample for the Nizhniy Novgorod region.Results.During 19 years of follow-up, the AH prevalence increased from 35.5 to 43.3%. Te awareness and treatment coverage reached 76.9 and 79.3%, respectively, in 2017. Achievement of the target BP with a single measurement also increased among patients receiving antihypertensive medication from 14.3 to 34.9%. For the treatment of AH, medium-acting antihypertensive drugs are used, ofen at suboptimal doses.Conclusion.Epidemiological indices of awareness, treatment coverage, and number of effectively managed patients with AH have improved. However, the AH prevalence has increased by 7.8% for 19 years, which indicates inefciency of the primary prevention of this disease.

Publisher

APO Society of Specialists in Heart Failure

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3